Skip to content

Author

Bo-Yang Li

We have 3 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Cross database bibliometric and knowledge mapping analysis of nanoplatform mediated tumor associated macrophage reprogramming

Nanoplatforms are evolving from passive delivery vehicles into multifunctional engineered systems capable of remodeling the tumor microenvironment. Tumor-associated macrophages (TAMs) are important biological interfaces because of their abundance, plasticity, and roles in immune suppression and therapeutic resistance....

Chang Su, Jia-Yue Gao, Bo-Yang Li et al. · 0 citations
Review Open access Aug 2026

Post-translational modification-governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review)

By organizing PTM biology around measurable state variables rather than modification class alone, the present review provides a phase-aware translational framework for candidate biomarker discovery, fit-for-purpose validation, constraint-guided stratification, and therapeutic prioritization in cancer immunotherapy.

Jing-Hao Pan, Bo-Yang Li, Ruo-Nan Lin et al. · 1 citation
Review Sep 2026

Metabolic and epigenetic plasticity of tumor-associated macrophages shapes immunosuppressive outputs and immune checkpoint response.

A context-dependent state-transition model is proposed in which pressures are decoded by interconnected nutrient- and stress-sensing pathways, integrated through mitochondrial bioenergetic and redox adaptation, and translated by metabolite-dependent chromatin remodeling into persistent TAM functional programs that cons...

Jing-Hao Pan, Bo-Yang Li, Lucy Yue Lau et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.